Mylan and King Terminate Merger

By Business Review Editor

Pharma Deals Review: Vol 2005 Issue 58 (Table of Contents)

Published: 5 Apr-2005

DOI: 10.3833/pdr.v2005.i58.701     ISSN: 1756-7874

Section: Mergers & Acquisitions



Mylan terminated the proposed acquisition of King Pharmaceuticals for US$4 B, as the two parties disagree upon the terms of the revised transaction...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details